TickerFactsScreenerDevelopers

Emmaus Life Sciences, Inc. (EMMA) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2010: $4.44M2011: $11.79M2012: $13.20M2013: $3.56M2014: $3.10M2015: $5.40M2016: $1.58M2017: $1.55M2018: $96.99M2019: $70.51M2020: $64.69M2021: $78.18M2022: $82.32M2023: $82.94M2024: $80.08M2025: $85.04M$85.04M
2010Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$85.04M+6.2%
2024$80.08M-3.4%
2023$82.94M+0.8%
2022$82.32M+5.3%
2021$78.18M+20.9%
2020$64.69M-8.2%
2019$70.51M-27.3%
2018$96.99M+6162.4%
2017$1.55M-1.8%
2016$1.58M-70.8%
2015$5.40M+74.4%
2014$3.10M-13.0%
2013$3.56M-73.0%
2012$13.20M+11.9%
2011$11.79M+165.5%
2010$4.44M—